Welcome Dr Gary Pitt as Epichem’s new Head of Chemistry!
Gary brings more than 20 years’ experience in drug discovery and development within the pharmaceutical industry and academia, in both the UK and Australia
He has created and lead chemistry teams for major research groups through many stages of the Drug Discovery Pipeline in areas including immunology, oncology, urology and infectious diseases.
He is a key inventor on more than twenty patents and has contributed to numerous medicinal chemistry projects that have progressed through to pre-clinical and Phase I and II clinical trials.
Gary joins Epichem from 360biolabs and, prior to that, the Walter and Eliza Hall Institute of Medical Research, where he was responsible for developing and implementing structures and processes to establish Australia’s first National Drug Discovery Centre (NDDC).
